XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   267,744      
Beginning balance at Dec. 31, 2023 $ 701,304 $ 268 $ 2,539,892 $ 219 $ (1,839,075)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (312,222)       (312,222)
Other comprehensive income (loss) 1,334     1,334  
Issuance of common stock in conjunction with equity plans (in shares)   6,068      
Issuance of common stock in conjunction with equity plans 7,703 $ 6 7,697    
Share-based compensation expense 55,003   55,003    
Ending balance (in shares) at Sep. 30, 2024   273,812      
Ending balance at Sep. 30, 2024 453,122 $ 274 2,602,592 1,553 (2,151,297)
Beginning balance (in shares) at Jun. 30, 2024   272,491      
Beginning balance at Jun. 30, 2024 492,700 $ 272 2,583,523 (523) (2,090,572)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (60,725)       (60,725)
Other comprehensive income (loss) 2,076     2,076  
Issuance of common stock in conjunction with equity plans (in shares)   1,321      
Issuance of common stock in conjunction with equity plans 812 $ 2 810    
Share-based compensation expense 18,259   18,259    
Ending balance (in shares) at Sep. 30, 2024   273,812      
Ending balance at Sep. 30, 2024 $ 453,122 $ 274 2,602,592 1,553 (2,151,297)
Beginning balance (in shares) at Dec. 31, 2024 294,418 294,418      
Beginning balance at Dec. 31, 2024 $ 506,594 $ 294 2,654,804 422 (2,148,926)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (506,005)       (506,005)
Other comprehensive income (loss) (7)     (7)  
Issuance of common stock in conjunction with equity plans (in shares)   7,435      
Issuance of common stock in conjunction with equity plans 3,428 $ 8 3,420    
Share-based compensation expense $ 32,080   32,080    
Ending balance (in shares) at Sep. 30, 2025 301,853 301,853      
Ending balance at Sep. 30, 2025 $ 36,090 $ 302 2,690,304 415 (2,654,931)
Beginning balance (in shares) at Jun. 30, 2025   300,350      
Beginning balance at Jun. 30, 2025 61,489 $ 300 2,677,853 267 (2,616,931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (38,000)       (38,000)
Other comprehensive income (loss) 148     148  
Issuance of common stock in conjunction with equity plans (in shares)   1,503      
Issuance of common stock in conjunction with equity plans 1,469 $ 2 1,467    
Share-based compensation expense $ 10,984   10,984    
Ending balance (in shares) at Sep. 30, 2025 301,853 301,853      
Ending balance at Sep. 30, 2025 $ 36,090 $ 302 $ 2,690,304 $ 415 $ (2,654,931)